MACE and other SAE
| Event | Active (n (95% CI)) | Placebo (n (95% CI)) | p |
| MACE at 30 days | 6 (0.19 to 1.79) | 10 (1) | 0.35 |
| MACE at 3 months | 10 (0.32 to 1.84) | 13 (1) | 0.54 |
| MACE at 1 year | 20 (0.59 to 2.22) | 18 (1) | 0.69 |
| MI (%) | 3.26 | 7.78 | 0.18 |
| Stroke (%) | 1.09 | 0 | 1.00 |
| Death (%) | 4.35 | 4.44 | 1.00 |
| CV hospitalisation (%) | 19.86 | 25 | 0.31 |
| Revascularisation (%) | 69.56 | 60 | 0.8 |
| Injection site reactions (%) | 15.22 | 15.56 | 0.95 |
| Other SAE (%) | 47.83 | 44.44 | 0.65 |